HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gill To Take CIR Director Role With Andersen’s Exit

This article was originally published in The Rose Sheet

Executive Summary

CIR Deputy Director Lillian Gill will replace Alan Andersen as director this summer, the group reported at its March 18-19 meeting. Gill was chosen because of her “hard-nosed” approach to regulation, says Andersen, who added that he will be available for some time as a consultant.

You may also be interested in...



CIR Director Gill Steps Down, Leaving Legacy Of Improved Transparency

Lillian Gill, director of the Cosmetic Ingredient Review, helped to bolster CIR’s international reputation during her four-year stint leading the group. CIR’s profile has risen as a result of her leadership, openness to outside stakeholder input and increased public interest in cosmetic ingredients’ safety overall.

CIR Panel Grapples With Interpreting NTP Retinyl Palmitate Study

The Cosmetic Ingredient Review Expert Panel examined the safety of retinol and related ingredients at its June 10-11 meeting, ultimately deciding not to make a safety determination until receiving further data from the National Toxicology Program.

CIR Expert Panel Nears Ingredient Review Milestone

The Cosmetic Ingredient Review Expert Panel has reviewed the safety of nearly half of all ingredients in use in cosmetic products, CIR Director Alan Andersen said during the group’s December meeting.

Related Content

UsernamePublicRestriction

Register

LL1132035

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel